Selection
Vaccine Name
Pathogen Name
Disease Name
Licensed?
VO ID
Tested in
Baboon
Hamster
Human
Macaque
Monkey
Mouse
Rat
0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021169
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.0333 MG/ML Injection
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021167
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021170
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021172
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Comirnaty 2023-2024]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021174
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021171
-
-
-
-
-
-
-
0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Comirnaty 2023-2024]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021173
-
-
-
-
-
-
-
0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021175
-
-
-
-
-
-
-
0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021176
-
-
-
-
-
-
-
0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Spikevax 2023-2024]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021178
-
-
-
-
-
-
-
0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021177
-
-
-
-
-
-
-
0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Spikevax 2023-2024]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021179
-
-
-
-
-
-
-
202-CoV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005320
-
-
-
-
-
X
-
AAHI-SC2
SARS-CoV-2
COVID-19
Clinical trial
VO_0005405
-
-
-
-
-
-
-
AAV5-RBD-S
SARS-CoV-2
COVID-19
Clinical trial
VO_0005336
-
-
-
-
-
-
-
Abdala
SARS-CoV-2
COVID-19
Clinical trial
VO_0005082
-
-
-
-
-
-
-
ABNCoV2
SARS-CoV-2
COVID-19
Clinical trial
VO_0005255
X
-
-
-
-
-
-
ABO1009-DP
SARS-CoV-2
COVID-19
Clinical trial
VO_0005391
-
-
-
-
-
-
-
ACM-001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005392
-
-
-
-
-
-
-
Ad5-nCoV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005144
-
-
X
-
-
-
-
Ad5-triCoV/Mac
SARS-CoV-2
COVID-19
Clinical trial
VO_0005339
-
-
-
-
-
-
-
AdCLD-CoV19
SARS-CoV-2
COVID-19
Clinical trial
VO_0004996
-
-
-
-
-
-
-
AdCOVID vaccine
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0005153
-
-
-
-
-
-
-
AdimrSC-2f
SARS-CoV-2
COVID-19
Clinical trial
VO_0005173
-
-
-
-
-
-
-
AG0301-COVID19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005165
-
-
-
-
-
-
-
AG0302-COVID19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005322
-
-
X
-
-
-
-
AKS-452
SARS-CoV-2
COVID-19
Clinical trial
VO_0004999
-
-
-
-
-
-
-
Almansour-001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005393
-
-
-
-
-
-
-
ARCoV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005161
-
-
X
X
-
X
-
ARCT-021
SARS-CoV-2
COVID-19
Clinical trial
VO_0005164
-
-
-
-
-
-
-
ARCT-154
SARS-CoV-2
COVID-19
Clinical trial
VO_0005347
-
-
-
-
-
-
-
ARCT-165
SARS-CoV-2
COVID-19
Clinical trial
VO_0005332
-
-
-
-
-
-
-
AV-COVID-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005079
-
-
-
-
-
-
-
AZD2816
SARS-CoV-2
COVID-19
Clinical trial
VO_0005319
-
-
X
-
-
-
-
bacTRL-Spike
SARS-CoV-2
COVID-19
Clinical trial
VO_0005174
-
-
-
-
-
-
-
Baiya SARS-CoV-2 Vax 1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005317
-
-
-
X
-
-
-
BBIBP-CorV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005166
-
-
-
X
-
-
-
BBV154
SARS-CoV-2
COVID-19
Clinical trial
VO_0005227
-
-
X
-
-
-
-
Betuvax-CoV2
SARS-CoV-2
COVID-19
Clinical trial
VO_0005406
-
-
-
-
-
-
-
ChAd-triCoV/Mac
SARS-CoV-2
COVID-19
Clinical trial
VO_0005342
-
-
-
-
-
-
-
ChAdV68-S
SARS-CoV-2
COVID-19
Clinical trial
VO_0005228
-
-
-
-
-
-
-
Chinese Academy of Medical Sciences COVID-19 vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005167
-
-
-
-
-
-
-
ChulaCov19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005175
-
-
-
-
-
-
-
CIGB-669
SARS-CoV-2
COVID-19
Clinical trial
VO_0005083
-
-
-
-
-
-
-
COH04S1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005394
-
-
-
-
-
-
-
Comirnaty
SARS-CoV-2
COVID-19
Licensed
VO_0004987
-
-
X
X
-
-
-
Corbevax
SARS-CoV-2
COVID-19
Clinical trial
VO_0005081
-
-
-
-
-
-
-
CoronaVac
SARS-CoV-2
COVID-19
Clinical trial
VO_0005141
-
-
-
X
-
X
X
CORVax12
SARS-CoV-2
COVID-19
Clinical trial
VO_0005183
-
-
-
-
-
-
-
CoV2 SAM
SARS-CoV-2
COVID-19
Clinical trial
VO_0005156
-
-
-
-
-
-
-
CoV2-OGEN1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005263
-
-
-
-
-
-
-
COVAC
SARS-CoV-2
COVID-19
Clinical trial
VO_0005194
-
-
-
-
-
-
-
COVAX-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005193
-
-
-
-
-
-
-
COVAXIN
SARS-CoV-2
COVID-19
Clinical trial
VO_0004991
-
-
X
X
-
-
-
CoVepiT
SARS-CoV-2
COVID-19
Clinical trial
VO_0005261
-
-
-
-
-
-
-
Covi Vax
SARS-CoV-2
COVID-19
Clinical trial
VO_0005349
-
-
-
-
-
-
-
COVI-VAC
SARS-CoV-2
COVID-19
Clinical trial
VO_0005187
-
X
-
-
-
-
-
COVID-19 aAPC vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005184
-
-
-
-
-
-
-
COVID-19 DNA vaccine by the University of Hong Kong and Immuno Cure 3 Limited
SARS-CoV-2
COVID-19
Licensed
VO_0005346
-
-
-
-
-
-
-
COVID-19 inactivated vaccine by the Scientific and Technological Research Council of Turkey
SARS-CoV-2
COVID-19
Clinical trial
VO_0005257
-
-
-
-
-
-
-
COVID-19 mRNA vaccine by CanSino Biologics
SARS-CoV-2
COVID-19
Clinical trial
VO_0005407
-
-
-
-
-
-
-
COVID-19 mRNA vaccine by Shanghai East Hospital and Stemirna Therapeutics
SARS-CoV-2
COVID-19
Clinical trial
VO_0005260
-
-
-
-
-
-
-
COVID-19 rNDV vector vaccine by Laboratorio Avi-Mex
SARS-CoV-2
COVID-19
Clinical trial
VO_0005259
-
-
-
-
-
-
-
COVID-19 subunit vaccine by HIPRA
SARS-CoV-2
COVID-19
Clinical trial
VO_0005321
-
-
-
-
-
-
-
COVID-19 subunit vaccine by National Vaccine and Serum Institute of China
SARS-CoV-2
COVID-19
Clinical trial
VO_0005248
-
-
-
-
-
-
-
COVID-19 subunit vaccine by PT Bio Farma
SARS-CoV-2
COVID-19
Clinical trial
VO_0005343
-
-
-
-
-
-
-
COVID-eVax
SARS-CoV-2
COVID-19
Clinical trial
VO_0005230
-
-
-
-
-
-
-
COVIDITY
SARS-CoV-2
COVID-19
Clinical trial
VO_0005344
-
-
X
-
-
-
-
Covifenz
SARS-CoV-2
COVID-19
Clinical trial
VO_0004992
-
-
-
-
-
-
-
COVIGEN
SARS-CoV-2
COVID-19
Clinical trial
VO_0005231
-
-
-
-
-
-
-
Covigenix VAX-001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005186
-
-
-
-
-
-
-
COVIran Barakat
SARS-CoV-2
COVID-19
Clinical trial
VO_0005229
-
-
-
-
-
-
-
CoviVac (Russia)
SARS-CoV-2
COVID-19
Clinical trial
VO_0005243
-
-
-
-
-
-
-
COVIVAC (Vietnam)
SARS-CoV-2
COVID-19
Clinical trial
VO_0005246
-
-
-
-
-
-
-
CV2CoV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005168
-
-
-
-
-
-
-
CVXGA1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005318
-
-
-
-
-
-
-
DelNS1-2019-nCoV-RBD-OPT1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005087
-
-
X
-
-
-
-
DoCo-Pro-RBD-1 + MF59
SARS-CoV-2
COVID-19
Clinical trial
VO_0005395
-
-
-
-
-
-
-
DS-5670a
SARS-CoV-2
COVID-19
Clinical trial
VO_0005245
-
-
-
-
-
-
-
EG-COVID
SARS-CoV-2
COVID-19
Clinical trial
VO_0005408
-
-
-
-
-
-
-
EgyVax
SARS-CoV-2
COVID-19
Clinical trial
VO_0005396
-
-
-
-
-
-
-
EpiVacCorona
SARS-CoV-2
COVID-19
Clinical trial
VO_0005088
-
-
-
-
-
-
-
EuCorVac-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005232
-
-
X
-
-
-
-
EXG-5003
SARS-CoV-2
COVID-19
Clinical trial
VO_0005249
-
-
-
-
-
-
-
GEMCOVAC-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005413
-
-
X
-
-
-
-
GLS-5310
SARS-CoV-2
COVID-19
Clinical trial
VO_0005089
-
-
X
-
-
-
-
GRAd-CoV2
SARS-CoV-2
COVID-19
Clinical trial
VO_0005169
-
-
X
-
-
-
-
GRT-R912
SARS-CoV-2
COVID-19
Clinical trial
VO_0005397
-
-
-
-
-
-
-
GX-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005170
-
-
X
-
-
-
-
hAd5-COVID-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005189
-
-
-
-
-
-
-
HDT-301
SARS-CoV-2
COVID-19
Clinical trial
VO_0005256
-
-
-
-
-
-
-
IIBR-100
SARS-CoV-2
COVID-19
Clinical trial
VO_0005090
-
-
-
-
-
-
-
IMP CoVac-1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005190
-
-
-
-
-
-
-
IN-B009
SARS-CoV-2
COVID-19
Clinical trial
VO_0005351
-
-
-
-
-
-
-
INO-4800
SARS-CoV-2
COVID-19
Clinical trial
VO_0005172
-
-
X
-
-
X
-
Johnson & Johnson COVID-19 vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005159
-
-
-
X
-
-
-
KBP-COVID-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005171
-
-
-
-
-
-
-
KCONVAC
SARS-CoV-2
COVID-19
Clinical trial
VO_0005084
-
-
-
-
-
-
-
KD-414
SARS-CoV-2
COVID-19
Clinical trial
VO_0005250
-
-
-
-
-
-
-
Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005253
-
-
-
-
-
-
-
licensed COVID-19 human vaccine
SARS-CoV-2
COVID-19
Licensed
VO_0004908
-
-
-
-
-
-
-
LNP-nCOV saRNA-02
SARS-CoV-2
COVID-19
Clinical trial
VO_0005276
-
-
-
-
-
-
-
LNP-nCoVsaRNA
SARS-CoV-2
COVID-19
Clinical trial
VO_0005143
-
-
-
-
-
-
-
LV-SMENP-DC
SARS-CoV-2
COVID-19
Clinical trial
VO_0005091
-
-
-
-
-
-
-
LVRNA009
SARS-CoV-2
COVID-19
Clinical trial
VO_0005414
-
-
-
-
-
X
-
LYB001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005348
-
-
X
-
-
-
-
MF59-adjuvanted SARS-CoV-2 Sclamp vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005258
-
-
X
-
-
-
-
MIPSCo-mRNA-RBD-1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005398
-
-
-
-
-
-
-
Moderna COVID-19 vaccine
SARS-CoV-2
COVID-19
Licensed
VO_0005157
-
-
X
X
-
-
-
mRNA-1073
SARS-CoV-2
COVID-19
Clinical trial
VO_0005409
-
-
-
-
-
-
-
mRNA-1273.211
SARS-CoV-2
COVID-19
Clinical trial
VO_0005277
-
-
X
-
-
-
-
mRNA-1273.214
SARS-CoV-2
COVID-19
Clinical trial
VO_0005415
-
-
X
-
-
-
-
mRNA-1273.351
SARS-CoV-2
COVID-19
Clinical trial
VO_0005233
-
-
-
-
-
-
-
mRNA-1273.529
SARS-CoV-2
COVID-19
Clinical trial
VO_0005416
-
-
-
-
-
X
-
mRNA-1283
SARS-CoV-2
COVID-19
Clinical trial
VO_0005185
-
-
-
-
-
-
-
MRT5500
SARS-CoV-2
COVID-19
Clinical trial
VO_0005241
-
-
-
-
-
-
-
MV-014-212
SARS-CoV-2
COVID-19
Clinical trial
VO_0005240
-
-
-
-
-
-
-
MVA-SARS-2-S
SARS-CoV-2
COVID-19
Clinical trial
VO_0005191
-
-
-
-
-
-
-
MVA-SARS-2-ST
SARS-CoV-2
COVID-19
Clinical trial
VO_0005262
-
-
-
-
-
-
-
MVC-COV1901
SARS-CoV-2
COVID-19
Clinical trial
VO_0005192
-
-
-
-
-
-
-
naNO-COVID
SARS-CoV-2
COVID-19
Clinical trial
VO_0005350
-
-
-
-
-
-
-
Nanocovax
SARS-CoV-2
COVID-19
Clinical trial
VO_0005092
-
X
-
-
-
-
-
NBP2001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005234
-
-
-
-
-
-
-
NDV-HXP-S
SARS-CoV-2
COVID-19
Clinical trial
VO_0005235
-
-
X
-
-
-
-
Noora
SARS-CoV-2
COVID-19
Clinical trial
VO_0005316
-
-
-
-
-
-
-
NVX-CoV2373
SARS-CoV-2
COVID-19
Clinical trial
VO_0005155
-
-
-
-
-
X
-
Omicron COVID-19 inactivated vaccine by China National Biotec Group Company Limited
SARS-CoV-2
COVID-19
Clinical trial
VO_0005417
-
-
-
-
-
-
-
Osvid-19
SARS-CoV-2
COVID-19
Clinical trial
VO_0005399
-
-
-
-
-
-
-
Oxford-AstraZeneca COVID-19 vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005158
-
-
X
X
-
-
-
PIKA Recombinant COVID-19 Vaccine
SARS-CoV-2
COVID-19
Licensed
VO_0005345
-
-
-
-
-
-
-
Prime-2-CoV_Beta
SARS-CoV-2
COVID-19
Clinical trial
VO_0005400
-
-
-
-
-
-
-
PTX-COVID19-B
SARS-CoV-2
COVID-19
Clinical trial
VO_0005236
-
-
-
-
-
X
-
QazCoVac-P
SARS-CoV-2
COVID-19
Clinical trial
VO_0005273
-
-
-
-
-
-
-
QazVac
SARS-CoV-2
COVID-19
Clinical trial
VO_0005093
-
-
-
-
-
-
-
Razi Cov Pars
SARS-CoV-2
COVID-19
Clinical trial
VO_0005226
-
-
-
-
-
-
-
RBD-HBsAg VLP
SARS-CoV-2
COVID-19
Clinical trial
VO_0005094
-
-
-
-
-
-
-
Recombinant SARS-CoV-2 vaccine (Sf9 cell)
SARS-CoV-2
COVID-19
Clinical trial
VO_0005095
-
-
-
-
-
-
-
ReCOV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005252
-
-
-
-
-
-
-
RH109
SARS-CoV-2
COVID-19
Clinical trial
VO_0005401
-
-
-
-
-
-
-
RQ3013
SARS-CoV-2
COVID-19
Clinical trial
VO_0005402
-
-
-
-
-
-
-
RVM-V001
SARS-CoV-2
COVID-19
Clinical trial
-
-
-
-
-
-
-
RVM-V001 vaccine
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0005403
-
-
-
-
-
-
-
S-268019
SARS-CoV-2
COVID-19
Clinical trial
VO_0005096
-
-
-
-
X
-
-
SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 10mcg/0.5mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006052
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 5mcg/0.5mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006053
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006054
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006055
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 30 mcg/0.3 mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006056
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006057
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent preservative free 3 mcg/0.2 mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006058
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 10 mcg/0.2mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006059
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006060
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 3 mcg/0.2mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006061
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006062
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose tris-sucrose formulation
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006063
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 50 mcg/0.5 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006064
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 25 mcg/0.25 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006065
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 50 mcg/0.5 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006066
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010153
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020193
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020194
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Comirnaty]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020195
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Spikevax]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020196
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
SARS-CoV-2
COVID-19
VO_0005436
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010142
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
SARS-CoV-2
COVID-19
VO_0005437
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010143
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010141
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010139
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010140
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020497
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020197
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020198
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020199
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020200
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020201
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020202
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020203
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020205
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension [Spikevax]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020206
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML [Spikevax]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020204
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020207
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020208
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020498
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020209
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020210
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020211
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020212
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020213
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020214
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020215
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020216
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020217
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020218
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020220
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension [Comirnaty]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020221
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML [Comirnaty]
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020219
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020222
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020223
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020224
-
-
-
-
-
-
-
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.01 MG/ML Injectable Suspension
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0021168
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010144
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020225
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension
SARS-CoV-2
COVID-19
FDA licensed vaccine role
VO_0020226
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, vector non-replicating
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0020227
-
-
-
-
-
-
-
SARS-COV-2 (COVID-19) vaccine, vector non-replicating Injectable Suspension
SARS-CoV-2
COVID-19
FDA licensed vaccine role
VO_0020228
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine (Spikevax Bivalent) Moderna
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006068
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine Product (Comirnaty Bivalent) Pfizer-BioNTech
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006069
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
SARS-CoV-2
COVID-19
VO_0005435
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology Chinese Academy of Sciences)
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006072
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Zifivax)
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006073
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006071
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA) CanSino Biological Inc./Beijing Institute of Biotechnology
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0006074
-
-
-
-
-
-
-
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
SARS-CoV-2
COVID-19
Licensed
VO_0006075
-
-
-
-
-
-
-
SARS-CoV-2 Vaccine YF-S0
SARS-CoV-2
COVID-19
Research
-
X
-
-
-
-
-
SARS-CoV-2 VLP Vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005251
-
-
-
-
-
-
-
SC-Ad6-1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005254
-
-
-
-
-
-
-
SCB-2019
SARS-CoV-2
COVID-19
Clinical trial
VO_0004994
X
-
-
-
-
-
-
SCB-2020S
SARS-CoV-2
COVID-19
Clinical trial
VO_0005315
-
-
-
-
-
-
-
SCTV01C
SARS-CoV-2
COVID-19
Clinical trial
VO_0005338
-
-
-
-
-
-
-
SII B.1.351
SARS-CoV-2
COVID-19
Clinical trial
VO_0005333
-
-
-
-
-
-
-
SII B.1.617.2
SARS-CoV-2
COVID-19
Clinical trial
VO_0005335
-
-
-
-
-
-
-
SII Bivalent
SARS-CoV-2
COVID-19
Clinical trial
VO_0005334
X
-
-
-
-
-
-
SKYCovione
SARS-CoV-2
COVID-19
Clinical trial
VO_0005197
-
-
-
-
-
-
-
Soberana 02
SARS-CoV-2
COVID-19
Clinical trial
VO_0005097
-
-
-
-
-
-
-
Soberana Plus
SARS-CoV-2
COVID-19
Clinical trial
VO_0005244
-
-
-
-
-
-
-
SpFN
SARS-CoV-2
COVID-19
Clinical trial
VO_0005237
X
-
-
-
-
-
-
SPIKEVAX vaccine
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0010359
-
-
-
-
-
-
-
Sputnik V
SARS-CoV-2
COVID-19
Clinical trial
VO_0005163
-
-
-
-
-
-
-
SYS6006
SARS-CoV-2
COVID-19
Clinical trial
VO_0005410
-
-
-
-
-
X
-
Turkovac
SARS-CoV-2
COVID-19
Clinical trial
VO_0005188
-
-
-
-
-
-
-
UB-612
SARS-CoV-2
COVID-19
Clinical trial
VO_0004995
-
-
X
-
-
-
-
UNAIR Inactivated COVID-19 Vaccine
SARS-CoV-2
COVID-19
Clinical trial
VO_0005411
-
-
-
-
-
-
-
V-01
SARS-CoV-2
COVID-19
Clinical trial
VO_0005247
-
-
X
-
-
-
-
V-01-351/V-01D Bivalence Vaccine
SARS-CoV-2
COVID-19
Licensed
VO_0005412
X
-
-
-
-
-
-
V590 vaccine
SARS-CoV-2
COVID-19
VO_0005195
-
-
-
-
-
-
-
V591 vaccine
SARS-CoV-2
COVID-19
authorized vaccine role
VO_0005098
-
-
-
-
-
-
-
VAT00002
SARS-CoV-2
COVID-19
Clinical trial
VO_0005085
-
-
-
-
-
-
-
VB10.2129
SARS-CoV-2
COVID-19
Clinical trial
VO_0005340
-
-
-
-
-
-
-
VB10.2210
SARS-CoV-2
COVID-19
Clinical trial
VO_0005341
-
-
-
-
-
-
-
VBI-2902a
SARS-CoV-2
COVID-19
Clinical trial
VO_0005238
X
-
-
-
-
-
-
VLA2001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005099
-
-
-
-
-
-
-
VLPCOV-01
SARS-CoV-2
COVID-19
Clinical trial
-
-
-
-
-
-
-
VXA-CoV2-1
SARS-CoV-2
COVID-19
Clinical trial
VO_0005196
-
X
-
-
-
-
-
VXS-1223
SARS-CoV-2
COVID-19
Clinical trial
VO_0005404
-
-
-
-
-
-
-
WIBP-CorV
SARS-CoV-2
COVID-19
Clinical trial
VO_0005160
-
-
-
-
-
-
-
ZF2001
SARS-CoV-2
COVID-19
Clinical trial
VO_0005142
-
-
-
-
-
X
-
ZyCoV-D
SARS-CoV-2
COVID-19
Clinical trial
VO_0005162
-
-
-
-
-
-
-